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Predicting the active absorption: the homology model for hPepT1
Background
 Reactive carbonyl species (RCS) are cytotoxic mediators generated by lipidoxidation of PUFAs, leading to 
alteration of cellular functions and inducing irreversible structural modifications to biomolecules. 
 RCS and the corresponding adducts with proteins (that is, carbonylated proteins) are widely used as 
biomarkers of lipidperoxidation and, in general, of oxidative stress. 
 Moreover, there are several convincing evidences supporting a pathogenic role for RCS, such as in the 
case of diabetic-related diseases, age-dependent tissue dysfunction, and metabolic distress syndrome. 
 Consequently, RCS, in addition to being a predictive biomarker, also represents a biological target for drug 
discovery.
• We recently found that the endogenous dipeptide carnosine (β-alanyl-L-histidine) is a specific quencher of 
α,β-unsaturated aldehydes [1]. Although carnosine is actively absorbed by intestinal transporter hPepT1, 
its therapeutic use is limited since it is unstable in human plasma due to the serum carnosinase activity (5). 
Moreover, the reactivity of carnosine towards RCS is markedly lower compared to other known quenchers.
• Hence, the rational design of new carnosine analogues should (1) increase the quenching activity of 
carnosine, maintaining its selectivity (2) confer plasma stability against human serum carnosinase, and (3) 
conserve an optimal recognition by hPepT1.
• Accordingly, in silico approaches can support the design of carnosine derivatives by (1) parameterizing the 
factors which govern the quenching activity, (2) predicting the effects of serum carnosinase and (3) 
modeling the recognition by hPepT1. 
• When the modifications were so significant to prevent the active transport, the marked hydrophilicity of 
carnosine analogues was modulated by designing prodrugs whose hydrolysis was predicted in silico by 
docking simulations with the major human carboxylesterases. 
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The ammonium head 
probably plays the most 
critical role since it 
realizes a reinforced H-
bond with Tyr588 as well 
as ion-pairs with Glu23
and/or Glu26. Notably, 
the contact between 
Tyr588 and ammonium 
head characterizes the 
most affinitive ligands.
The carboxy terminus 
appears less involved 
in ligand recognition, 
since it stabilizes only 
H-bonds with the 
backbone of Ala295, 
Leu296, and Phe297
without forming strong 
ionic interactions
The residues which interact with the side chains are heterogeneous, justifying the ability of hPepT1 to 
interact with structurally diverse substrates. It is possible to recognize a set of residues involved in the 
interaction with the N-terminal side chain (SC1) such as Asn22, Glu23, and Phe293, while the C-
terminal side chain (SC2) contacts Trp294, Ile331, Glu291 and Thr327.
The central peptide bond can stabilize H-bonds 
with backbone atoms of Phe293 and Trp294. 
pKi = 0.235 ∆distance – 7.912 10-3 Zapbind +1.534 Int_Tyr588 - 0.480 
n = 50; r2 = 0.85; s = 0.45; F = 89.92
Docking results suggest that the most 
affinitive compounds have a distance 
between charged termini about equal to 6 
Å. ∆distance defines the difference 
between the distance value of a given 
ligand and the optimal distance (6.02 Å) 
as evidenced by the most affinitive 
ligand. 
Zapbind accounts for the ionic 
interactions. Despite the known 
predilection of hPepT1 for hydrophobic 
ligands, the role of Zapbind score 
emphasizes the relevance of the polar 
interactions mostly realized by the 
ligand’s charged groups. 
Given the beneficial role of the 
interaction between Tyr588 and 
ammonium head, we introduced a 
binary descriptor (Int_Tyr588), which 
is equal to 1 for substrates which 
realize such a reinforced H-bond and 
0 otherwise. 
The hPepT1 structure was modeled by fragments based on the resolved structure of lactose permease, LacY. Docking analyses
involved a set of 50 known substrates and allowed the identification of a common pattern of interactions [3].
Docking results confirmed the key role of chiral centers in hPepT1 
recognition, thus explaining why D-car derivatives are not actively 
transported. Docking results also allowed to derive a reliable 
correlative equation which was used to predict the affinity of 
carnosine analogues. The figure shows the putative complex 
carnosine-hPepT1. The predicted affinity is in line with the 
experimental value: 1.41 mM (pred) vs. 2.48 mM (exp).
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Predicting the plasma stability: the serum carnosinase
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The human serum carnosinase was modeled using the structure of β-alanine
synthase as template. Docking analyses allowed to identify the ligand moieties 
which are critically involved in enzyme recognition, emphasizing the key role of 
the contacts with metal ions [4].
Furthermore, docking studies can be used to predict the plasma stability of 
novel analogues. For instance, they can well explain why D-carnosine is not 
recognized by serum carnosinase and is stable in human plasma. 
Predicting the prodrug hydrolysis: the carboxylresterase 1
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The design of suitable prodrugs for D-carnosine was supported by 
docking analyses involving the human carboxylesterase-1. Such 
studies firstly involved a set ok known substrates and allowed the 
identification of key residues involved in complex stabilization as 
well as the development of a robust predictive equations [5].
The obtained results were then exploited to rationalize the stability 
of a set of D-carnosine prodrugs also predicting the more labile 
function for the bi-protected derivatives.
Globally, the performed simulations lead to the design of octyl-D-
carnosine as most promising prodrug for clinical studies.
Conclusions: summarizing the obtained SARs
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Based on obtained SARs and 
performed simulations, the 
rational design of new 
carnosine analogues followed 
such a pathway:
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Enhancing the quenching activity
The modifications aimed to enhance the reactivity of the amino group are not largely exploitable since they would 
mine the specificity quenching also physiological aldehydes. Conversely,  the specific Michael adduction can be 
optimized, by (1) modifying the imidazole ring to increase its nucleophilicity and (2) modulating the conformational 
profile of the Schiff base intermediate in order to favor a close conformation in which the imidazole ring approaches 
the reactive C3 to form the corresponding Michael adduct. 
The key role of conformational profile: the case of Schiff base carnosine-HNE
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Noticeably, suitable modifications in aryl-analogues enhances 
the folded percentage up to 75% with a corresponding increase 
of quenching activity as seen in 4-metoxybenzyl derivative [2]. 
The Michael adduction can be parameterized calculating the nucleophilicity of new analogues using suitable indices 
mainly based on ab initio simulations. Preliminary analyses confirmed the significant reactivity of imidazole ring and 
unveiled the promising activity of furan ring.
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